Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: A phase I-II trial

European Journal of Surgical Oncology

Volumn 31, Issue 8, 2005, Pages 897-904

  van Ijken, M G A ^a   van Etten, B ^a   Guetens, G ^b   de Bruijn, E A ^b   ten Hagen, T L M ^a   Wiggers, Th ^a   Eggermont, A M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Balloon catheter; Hypoxic perfusion; Melphalan; MMC; Non resectable pelvic tumours; Pelvis; Phase I II trial; Stop flow

Indexed keywords

MELPHALAN; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; AORTA; ARTICLE; BALLOON CATHETER; BLADDER CANCER; BLOOD TOXICITY; CANCER RECURRENCE; CANCER SURVIVAL; CAVA VEIN; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; GASTROINTESTINAL TOXICITY; HEMATURIA; HUMAN; HYPOXIC PELVIC PERFUSION; ILEUS; INOPERABLE CANCER; LIVER TOXICITY; MALE; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN PERFUSION; PAIN; PAIN ASSESSMENT; PELVIS CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECTUM CANCER; SIDE EFFECT; TREATMENT OUTCOME; URINE RETENTION; VULVA CANCER;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; BALLOON DILATATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELPHALAN; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; NEOPLASM STAGING; PAIN MEASUREMENT; PELVIC NEOPLASMS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 26444471323     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.06.004     Document Type: Article

References (49)

1. T. Wiggers M.R. de Vries B. Veeze-Kuypers Surgery for local recurrence of rectal carcinoma Dis Colon Rectum 39 3 1996 323-328
2. T. Holm B. Cedermark L.E. Rutqvist Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy Br J Surg 81 3 1994 452-455
3. R.J. Heald A new approach to rectal cancer Br J Hosp Med 22 3 1979 277-281
4. J.K. MacFarlane R.D. Ryall R.J. Heald Mesorectal excision for rectal cancer Lancet 341 8843 1993 457-460
5. K. Havenga W.E. Enker J. Norstein Y. Moriya R.J. Heald H.C. van Houwelingen et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients Eur J Surg Oncol 25 4 1999 368-374
6. P.M. Sagar J.H. Pemberton Surgical management of locally recurrent rectal cancer Br J Surg 83 3 1996 293-304
7. A.L. Martling T. Holm L.E. Rutqvist B.J. Moran R.J. Heald B. Cedemark Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project Lancet 356 9224 2000 93-96
8. R.J. Aitken Mesorectal excision for rectal cancer Br J Surg 83 2 1996 214-216
9. M. Huguier S. Houry Treatment of local recurrence of rectal cancer Am J Surg 175 4 1998 288-292
10. F. Michelassi L. Vannucci J.J. Ayala R. Chappel R. Goldberg G.E. Block Local recurrence after curative resection of colorectal adenocarcinoma Surgery 108 4 1990 787-792 [discussion 792-3]
11. M. Mohiuddin G. Marks Patterns of recurrence following high-dose preoperative radiation and sphincter-preserving surgery for cancer of the rectum Dis Colon Rectum 36 2 1993 117-126
12. T. Wiggers G.H. Mannaerts A.W. Marinelli H. Martijn H.J. Rutten Surgery for locally recurrent rectal cancer Colorectal Dis 5 5 2003 504-507
13. H.J. Wanebo R.J. Koness M.P. Vezeridis S.I. Cohen D.E. Wrobleski Pelvic resection of recurrent rectal cancer Ann Surg 220 4 1994 586-595
14. N. Saunders Pelvic exenteration: By whom and for whom? Lancet 345 8941 1995 5-6
15. WHO handbook for reporting results of cancer treatment. WHO Offset Publication no. 48: WHO Offset; 1979.
16. J. Hofland R. Tenbrinck I.M.G. van Ijken C.H. van Eijck A.M. Eggermont W. Erdmann Cardiovascular effects of simultaneous occlusion of the inferior vena cava and aorta in patients treated with hypoxic abdominal perfusion for chemotherapy Br J Anaesth 88 2 2002 193-198
17. U.R. Tjaden E.A. de Bruijn Chromatographic analysis of anticancer drugs J Chromatogr 531 1990 235-294
18. G. de Boeck K. van Cauwenberghe A.M. Eggermont E.A. de Bruin Determination of melphalan and hydrolysis products in body fluids by GC-MS J High Resolut Chromatogr 20 1997 697-700
19. M. Kornmann U. Butzer J. Blatter H.G. Beger K.H. Link Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer Eur J Surg Oncol 26 6 2000 583-587
20. P.J. Kuppen H. Schuitemaker L.J. van't Veer E.A. de Bruijn A.T. van Oosterom P.I. Schrier cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines Cancer Res 48 12 1988 3355-3359
21. P.H. Slee E.A. de Bruijn P. Leeflang P.J. Kuppen L. van den Berg A.T. van Oosterom Variations in exposure to mitomycin C in an in vitro colony-forming assay Br J Cancer 54 6 1986 951-955
22. S. Guadagni G. Fiorentini G. Palumbo M. Valenti F. Russo M. Cantore et al. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer Arch Surg 136 1 2001 105-112
23. E. Strocchi R.V. Iaffaioli G. Facchini G. Mantovani S. Ricci G. Cavallo et al. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers Eur J Surg Oncol 30 6 2004 663-670
24. J.F. Thompson M. Liu L.D. Watson D.M. Sheldon M.S. Stephan D.W. Storey et al. A percutaneous aortic stop-flow infusion technique for regional cytotoxic therapy of the abdomen and pelvis Reg Cancer Treat 7 1994 202-207
25. K.R. Aigner Regional chemotherapy-editorial review article Reg Cancer Treat 2 1994 55-66
26. M.G. van Ijken B. van Etten G. Guetens T.L. ten Hagen J. Jeekel E.A. de Bruijn et al. Balloon catheter hypoxic abdominal perfusion with mitomycin C and melphalan for locally advanced pancreatic cancer: A phase I-II trial Eur J Surg Oncol 30 6 2004 671-680
27. M.G. van Ijken E.A. de Bruijn T.L. ten Hagen G. de Boeck C.H. van Eijck A.M. Eggermont Balloon catheter hypoxic abdominal and pelvic perfusion with tumour necrosis factor-alpha, melphalan and mitomycin C: A pharmacokinetic study in pigs Eur J Surg Oncol 30 6 2004 699-707
28. P. Pilati S. Mocellin D. Miotto C.R. Rossi L. Codello M. Foletto et al. Stop-flow technique for loco-regional delivery of antiblastic agents: Literature review and personal experience Eur J Surg Oncol 28 5 2002 544-553
29. E.S. Klein G.Y. Ben-Ari M.Z. Papa R. Adar A. Bass Vascular complications of total abdominal perfusion and aortic stop-flow infusion J Surg Oncol 61 1 1996 17-19
30. B.A. Teicher J.S. Lazo A.C. Sartorelli Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells Cancer Res 41 1 1981 73-81
31. P. Vaupel F. Kallinowski P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review Cancer Res 49 23 1989 6449-6465
32. P.S. Turk J.F. Belliveau J.W. Darnowski M.C. Weinberg L. Leenen H.J. Wanebo Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique Arch Surg 128 5 1993 533-538
33. N.J. Lygidakis G. Sgourakis P. Aphinives Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial Hepatogastroenterology 46 27 1999 2035-2038
34. D. Christoforidis O. Martinet F.J. Lejeune F. Mosimann Isolated liver perfusion for non-resectable liver tumours: A review Eur J Surg Oncol 28 8 2002 875-890
35. D.L. Bartlett S.K. Libutti W.D. Figg D.L. Fraker H.R. Alexander Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer Surgery 129 2 2001 176-187
36. A. Marinelli A.L. Vahrmeijer C.J. van de Velde Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases Recent Results Cancer Res 147 1998 83-94
37. L.M. de Brauw A. Marinelli C.J. van de Velde J. Hermans U.R. Tjaden C. Erkelens et al. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil Cancer Res 51 6 1991 1694-1700
38. A.M. Eggermont H. Schraffordt Koops J.M. Klausner B.B. Kroon P.M. Schlag D. Lienard et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience Ann Surg 224 6 1996 756-764 [discussion 764-5]
39. 14C-labeled mitomycin C J Surg Res 59 3 1995 415-419
40. K.R. Aigner K. Kaevel Pelvic stopflow perfusion and hypoxic pelvic perfusion with MMC and melphalan for recurrent rectal cancer Reg Cancer Treat 7 1994 6-11
41. S. Guadagni F. Russo C.R. Rossi P.L. Pilati D. Miotto G. Fiorentini et al. Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma Am J Surg 183 1 2002 28-36
42. H.J. Wanebo J.F. Belliveau A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion Cancer Chemother Pharmacol 43 5 1999 427-434
43. K.R. Aigner Pelvic stopflow infusion and hypoxic pelvic perfusion-techniques and pharmacokinetics Reg Cancer Treat 8 1995 6-12
44. M.G. van Ijken E.A. de Bruijn G. de Boeck T.L. ten Hagen J.R. van der Sijp A.M. Eggermont Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: A pharmacokinetic study in pigs Ann Surg 228 6 1998 763-770
45. E. Chrysos J. Tsiaoussis K. Alexandra H. Athanasakis D. Tsetis C. Varveris et al. Treatment of unresectable malignant abdominal, pelvic and thoracic tumors using abdominal pelvic and thoracic stop-flow chemotherapy Anticancer Res 21 5 2001 3669-3675
46. S. Guadagni M. Santinami R. Patuzzo P.L. Pilati D. Miotto M. Deraco et al. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: A pilot study Melanoma Res 13 1 2003 51-58
47. M. Delaney M. Stancu G. Begossi G.J. Elfenbein H.J. Wanebo Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow stem cell support for advanced endometrial cancer Med Health R I 86 8 2003 252-255
48. H. Muller R. Hilger Curative and palliative aspects of regional chemotherapy in combination with surgery Support Care Cancer 11 1 2003 1-10
49. H.J. Wanebo J. Belliveau G. Begossi A. Levy Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer Colorectal Dis 5 5 2003 508-514